Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Rang in aandelen #28133
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aandeelprijs
$0.37430781
Laatst gesynchroniseerd: 2026-08-19
Marktkapitalisatie
$28.37M
Verandering (1 dag)
2.00%
Verandering (1 jaar)
-13.46%
Land
CA
Handel Defence Therapeutics Inc. (DTC)

Categorie

Dividendrendementgeschiedenis voor Defence Therapeutics Inc. (DTC)
Het dividendrendement (TTM) van Defence Therapeutics Inc. (aandelsymbool: DTC) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Defence Therapeutics Inc. (DTC) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH